Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
Would you consider APBI in a primary breast adenoid cystic carcinoma?
Assuming the patient is otherwise a candidate for APBI.
Answer from: Radiation Oncologist at Community Practice
I would be reluctant based on local spread pattern.
Comments
Radiation Oncologist at Henry Ford Health System
Given this tumor type's high degree of local sprea...
3084
Sign in or Register to read more
7769
Related Questions
Does radiation therapy (ex. to the breast) in patients with CDK4 mutations increase the risk of developing melanoma?
Would you offer ultrahypofractionated 5-fraction whole breast only for a women with ER-/HER2+/cN+ disease with pCR following neoadjuvant systemic therapy?
What is your preferred sequencing of adjuvant chemotherapy and PMRT for node + breast cancer?
What is the maximum dose that you would give to residual unresectable gross disease in the axilla in the setting of recurrent breast cancer s/p ALND?
Would you offer prone APBI with IMRT/VMAT?
What is your preferred method of surveillance after mastectomy?
Is 5fx APBI and no endocrine therapy a new standard of care for women over 70 years old with low-risk breast cancer given the interim analysis of the EUROPA trial?
How do you choose between ALND and RNI in the setting of LYMPHA or S-Lympha surgery?
If a patient has multiple PET-avid level 3, supraclavicular, or IMN nodes that are small and would have been considered negative by size criteria with traditional imaging, that are no longer positive on PET after chemotherapy, would you try to boost these nodes?
In the post-mastectomy setting, are there situations where only the regional nodes or targeted nodal basis are covered?
Given this tumor type's high degree of local sprea...